Exploring the SERMs, SERDs, and CDK4/6 Inhibitors Market

Understanding Estrogen Receptor-Positive (ER+) Breast Cancer Estrogen receptor-positive (ER+) breast cancer is the most common form, making up about 70% of breast cancer diagnoses. This type of cancer grows in response to estrogen, making hormone therapy a key component of treatment. Over the years, targeted therapies have significantly improved o

read more